# MTD Group completes acquisition of Ypsomed's pen needle and BGM businesses

Medical Technology and Devices (MTD) completed the acquisition of Ypsomed's Pen Needles and Blood Glucose Monitoring Systems businesses, initially announced in March 2024. The deal strengthens MTD's position as the world's second-largest pen needle producer, with total production capacity exceeding 2.5 billion pen needles.

- Type: Acquisition
- Announced: 2024-08-02
- Status: completed
- Capacity: 2.5 billion pen needles
- Products: pen needles, blood glucose monitoring systems
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Ypsomed](https://endata.com/companies/9625.md) (target)
- [MTD](https://endata.com/companies/57329.md) (acquirer)

## Sources

- [prnewswire.com](https://www.prnewswire.com/news-releases/mtd-group-completes-the-acquisition-of-ypsomeds-pen-needles-and-blood-glucose-monitoring-systems-and-announces-a-significant-investment-plan-for-its-european-production-sites-302212655.html), 2024-08-02: "This acquisition marks a major step forward in MTD's mission to provide superior diabetes and obesity care solutions on a global scale."
- [ypsomed.com](https://www.ypsomed.com/en/news-insights/news/press-releases/news-reader-detail-page/ypsomed-and-mtd-complete-the-sale-of-the-pen-needle-and-bgm-business), 2024-08-02: "The completion of this acquisition is a transformative milestone for MTD Group."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.